Enter your email address below and subscribe to our newsletter

Patient Education

Share your love

How to Slow The Myopia In Children With Contact Lenses

Myopia, or short-sightedness, is one of the most common eye health issues in children and means that they can’t see objects that are far away, causing their vision to blur. Symptoms usually appear between the ages of 8 and 12…

The Basics of Excimer Laser

In the field of ophthalmology, laser technology is used in many basic and clinical disciplines and specialities. It has played an important role in promoting the development of ophthalmology. Advancements in technology have allowed improvements in the surgical safety, efficacy, speed…

Slowing The Myopia In Children With Contact Lenses

Are you prescribing contact lenses for myopia management? We ask this question at the start of every myopia management lecture we deliver. Over the past two years, we have gone from having audiences with no hands raised to now having…

Eye Drops Could Revolutionize Wet AMD Therapy

A novel compound, created at the University of Illinois Chicago, holds the potential to provide an alternative to injections for the vast population suffering from an eye condition leading to blindness. This condition, known as wet age-related macular degeneration (AMD),…

Scientists Develop AI to Help Doctors Pick Best IOL Option

Scientists have developed computer models of patients’ eyes to determine the most suitable intraocular lenses and to offer patients a visual simulation of their expected vision with these lenses. Although millions of individuals have undergone LASIK eye surgery since it…

What Is Bullous Keratopathy and How to Manage It

What Is Bullous Keratopathy? Bullous keratopathy (BK) is a pathological condition characterized by the presence of fluid-filled blisters or “bullae” on the cornea, which is the clear front surface of the eye. The main underlying factor leading to the formation…

LumiThera Receives $2.3M NIH Grant for Dry AMD Trial

LumiThera has been granted a small business innovative research (SBIR) phase 2 grant from the National Institute of Health (NIH), totaling up to $2.3 million in funding over a span of 2 years. This NIH/NEI grant is geared towards supporting…

What Is Endophthalmitis and How to Manage It

What Is Endophthalmitis? Endophthalmitis is a rare but serious eye condition that can lead to vision loss if not promptly treated. This infection targets the interior structures of the eye, causing inflammation and potential damage. Understanding the symptoms, causes, treatment…

What Is Bull’s Eye Maculopathy and How to Manage It

What Is Bull’s Eye Maculopathy? Bull’s Eye Maculopathy is a specific form of retinal disease characterized by changes in the pigmentation of the macular region of the retina, often presenting as a ‘bull’s eye’ pattern. The macula is the central…

Tenpoint Therapeutics Launches with $70M Financing

Tenpoint Therapeutics, a biotechnology company focused on vision-restoring engineered cell-based therapeutics and in vivo reprogramming for degenerative ocular diseases, has announced its launch with a $70 million Series A financing. The funding will be used to develop the company’s regenerative…

Stay informed and not overwhelmed, subscribe now!